Publication:
Sacral neuromodulation therapy for urinary and defecatory disorders: experience in a Latin American public hospital

Simple item page
dc.contributor.authorMass, Marcelo
dc.contributor.authorArévalo, Diego
dc.contributor.authorAleuanlli, Isidora
dc.contributor.authorSantis, Fernanda
dc.contributor.authorMaluenda, Andrea
dc.contributor.authorDines, Eitan
dc.contributor.authorCohen, Miriam
dc.contributor.authorSaavedra, Álvaro
dc.contributor.authorRaby, Trinidad
dc.contributor.authorBlumel, Bernardita
dc.contributor.authorCuevas, Rodrigo
dc.contributor.authorPohlhammer, Simone
dc.contributor.authorAlarcon, Gabriela
dc.contributor.authorArellano, Marco
dc.contributor.authorPizarro, Javier
dc.date.accessioned2024-12-16T20:45:23Z
dc.date.available2024-12-16T20:45:23Z
dc.date.issued2024
dc.description.abstractObjective: To show the experience of a Latin American public hospital, with SNM in the management of either OAB, NOUR or FI, reporting feasibility, short to medium-term success rates, and complications. Methods: A retrospective cohort was conducted using data collected prospectively from patients with urogynecological conditions and referred from colorectal surgery and urology services between 2015 and 2022. Results: Advanced or basic trial phases were performed on 35 patients, 33 (94%) of which were successful and opted to move on Implantable Pulse Generator (GG) implantation. The average follow-up time after definitive implantation was 82 months (SD 59). Of the 33 patients undergoing, 27 (81%)reported an improvement of 50% or more in their symptoms at last follow-up. Moreover, 30 patients (90%) with a definitive implant reported subjective improvement, with an average PGI-I "much better" and 9 of them reporting to be "excellent" on PGI-I. Conclusion: SNM is a feasible and effective treatment for pelvic floor dysfunction. Its implementation requires highly trained groups and innovative leadership. At a nation-wide level, greater diffusion of this therapy among professionals is needed to achieve timely referral of patients who require it.
dc.description.versionVersión Aceptada
dc.identifier.citationMass-Lindenbaum M, Arévalo-Vega D, Aleuanlli I, Santis-Moya F, Maluenda A, Dines E, Cohen-Vaizer M, Saavedra Á, Raby T, Blumel B, Cuevas R, Pohlhammer S, Alarcon G, Albornoz MA, Pizarro-Berdichevsky J. Sacral neuromodulation therapy for urinary and defecatory disorders: experience in a Latin American public hospital. Rev Bras Ginecol Obstet. 2024 Mar 15;46:e-rbgo11. doi: 10.61622/rbgo/2024AO11
dc.identifier.doihttps://doi.org/10.61622/rbgo/2024AO11
dc.identifier.urihttps://hdl.handle.net/11447/9492
dc.language.isoen
dc.subjectElectric stimulation therapy
dc.subjectFecal incontinence
dc.subjectIncontinence
dc.subjectNon-obstructive urinary retention
dc.subjectSacral neuromodulation
dc.subjectUrinary bladder
dc.subjectoveractive
dc.titleSacral neuromodulation therapy for urinary and defecatory disorders: experience in a Latin American public hospital
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceRevista brasileira de ginecologia e obstetrícia : revista da Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
dspace.entity.typePublication

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Sacral neuromodulation therapy for urinary and defecatory disorders experience in a Latin American public hospital.pdf
Size:
435.54 KB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services